Therefore, our research further reveals that ECM1 may play a role as a member of a complex regulatory network in cancer cells and plays an important role in reversing ovarian cancer PARP inhibitor resistance through PS VII. This evidence concerns the gene ECM1 and ovarian carcinoma.